SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Spotlight Innovation Inc. (STLT)

STLT RSS Feed
Add STLT Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 10/24/2017 11:19:21 AM - Followers: 32 - Board type: Free - Posts Today: 0

 



Spotlight Innovation Inc. (OTCQB: STLT) specializes in identifying, acquiring and incubating companies
which have unique intellectual property (IP) in the medical sector.
The Company utilizes relationships with the nation’s leading academic and institutional IP developers to
locate promising IP technologies with potential for market share capture.
With their support, development, resources and strategic planning expertise, Spotlight Innovation believes
they can develop IP that will have a positive effect on healthcare.
They intend to partner with proven sector leaders on commercialization once technologies are fully developed.

http://www.otcmarkets.com/stock/STLT/profile
 
Verified Company Profile3/29/2016
Contact Info
  • 6750 Western Parkway
    Suite 200-226
    West Des Moines, IA 50266
 
TLT Security Details
Share Structure
  Market Value1 $9,355,615 a/o Aug 29, 2016
  Authorized Shares 4,000,000,000 a/o Nov 04, 2014
  Outstanding Shares 15,856,974 a/o Aug 02, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 2,342,931 a/o Aug 02, 2016
  Par Value 0.001
Transfer Agent(s)
VStock Transfer LLC
Shareholders
Shareholders of Record 77 a/o Aug 02, 2016
Security Notes
  • Capital Change=shs increased by 14 for 1 split. Payable upon surrender. Pay date=08/19/2008.
    Capital Change=Stk. Div.=50% Ex-date=04/15/2009. Rec date=03/26/2009. Pay date=04/14/2009.
    Capital Change=shs decreased by 1 for 500 split. Ex-date=12/19/2013.










ZACKs Analyst report issued August 2015 http://share.myflare.com/MqVG9g

http://www.spotlightinnovation.com/download-whitepaper/

Website: http://www.spotlightinnovation.com

LinkedIn Company Page: http://www.linkedin.com/company/spotlight-innovation

YouTube/Google+ Company: http://www.youtube.com/user/spotlightinnovation

Twitter: https://twitter.com/SpotlightInno

Facebook: https://www.facebook.com/SpotlightInnovation

SPOTLIGHT INNOVATION INC.

6750 Westown Pkwy, Suite 200-226
West Des Moines, IA 50266
Phone: 515-274-9087

Milestones:

2015

JANUARY 2015
Spotlight Innovation subsidiary 
Celtic Biotech Iowa granted Patent by the U.S. Patent and Trademark Office

JANUARY 2015
Spotlight Innovation signs 
Memorandum of Understanding (MOU) with Black Swan LLC

2014

OCTOBER 2014
Spotlight Innovation signs 
Letter of Intent to Acquire Memcine Pharmaceuticals

SEPTEMBER 2014
Spotlight Innovation 
retains Jerry Cirino as Special Advisor

SEPTEMBER 2014
Spotlight Innovation 
retains Barwicki Investor Relations

AUGUST 2014
Spotlight Innovation
 publishes White Paper “Midwest Universities are Cultivating IP Commercialization Success”

JULY 2014
Spotlight Innovation receives 
$250,000 Line of Credit from Denver Savings Bank

JUNE 2014
Spotlight Innovation
 hires Dr. Hostelley as CFO

JUNE 2014
Spotlight Innovation closes 
equity placement of more than $41M: released to Company under certain specified conditions

JUNE 2014
Share exchange agreement finalized between Celtic Biotech Iowa and Celtic Biotech LTD, completing Celtic Biotech LTD acquisition

APRIL 2014
Spotlight Innovation
 receives $752,325 Line of Credit from Denver Savings Bank, secured by Jared DeVries

MARCH 2014
Celtic Biotech Iowa, Inc., becomes wholly-owned subsidiary of Spotlight Innovation Inc.

2013

DECEMBER 2013
AEXP/Spotlight Innovation merger completed

 

March 10, 2015
Spotlight Innovation subsidiary Celtic Biotech Iowa licenses promising therapy for Chronic Kidney Disease

Spotlight Innovation Inc. (OTCQB: STLT) announces that its subsidiary Celtic Biotech Iowa, Inc., entered into an exclusive, world-wide (excluding China) license agreement to develop and market a patent-pending invention related to the treatment of acute and chronic nephropathy, Use of Cardiotoxin for the Treatment of Chronic Kidney Disease (CKD).
Read more…


January 15, 2015
Spotlight Innovation subsidiary Celtic Biotech Iowa granted Patent by the U.S. Patent and Trademark Office

Spotlight Innovation Inc. (OTCQB: STLT) announces that its subsidiary Celtic Biotech Iowa Inc. has been granted U.S. Patent entitled Crotoxin Administration for Cancer Treatment and Pain Relief.  The invention relates to Crotoxin compositions for intravenous administration and methods of use of Crotoxin for the treatment of pain and/or for the treatment of neurologic and neuromuscular disorders.
Read more…


January 6, 2015
Spotlight Innovation signs Memorandum of Understanding (MOU) with Black Swan LLC

Spotlight Innovation Inc. (OTCQB:STLT) announces that it has entered into a Memorandum of Understanding with Black Swan LLC. Under the agreement, Black Swan will assist with activities such as identifying applicable government grants and loans, affecting beneficial changes to the legislative environment, advancing emerging technologies, identifying business partners, and developing new markets, particularly in the government sector.
Read more…


December 16, 2014
Spotlight Innovation announces change of Transfer Agent

Spotlight Innovation Inc. (OTCQB:STLT) announces today that effective December 16, 2014, all communications related to shareholder transactions should be directed to VStock Transfer, LLC, 18 Lafayette Place, Woodmere, NY 11598.
Read more…


December 4, 2014
Celtic Biotech Iowa requests reactivation and transfer of National Drug Code registration

Spotlight Innovation Inc. (OTCQB:STLT) announces that a request was submitted to the Center for Drug Evaluation and Research at the Food and Drug Administration to reactivate and transfer the Celtic Biotech (Ireland) National Drug Code (NDC) registration to Celtic Biotech Iowa Inc. in anticipation of the manufacture and commercialization of a proprietary transdermal delivery gel product.
Read more…


October 14, 2014
Spotlight Innovation signs Letter of Intent to Acquire Memcine Pharmaceuticals

Spotlight Innovation Inc. (OTCQB:STLT) announced that it has signed a Letter of Intent to acquire majority ownership in Memcine Pharmaceuticals Inc., located at the University of Iowa Research Park in Coralville, Iowa. Memcine Pharmaceuticals is developing its Immunoplex™ vaccine platform technology, which is designed to use the body’s own naturally occurring targeting system to deliver vaccine components to immune cells and stimulate a robust response.
Read more…


October 1, 2014
Spotlight Innovation Retains Jerry Cirino as Special Advisor

Spotlight Innovation Inc. (OTCQB: STLT) has hired Jerry Cirino as a Special Advisor to provide business development expertise and to advise the Company on strategic opportunities and transactions.
Read more…


September 24, 2014
Spotlight Innovation Retains Barwicki Investor Relations to Provide Global Investor Relations Program

Spotlight Innovation, Inc. (OTCQB: STLT) announced that it has retained Barwicki Investor Relations, a New York-based investor relations firm, to expand the Company’s strategic investor relations program. Barwicki Investor Relations is providing financial community and media relations, and editorial, consulting and advisory services.
Read more…


August 27, 2014
Spotlight Innovation white paper focuses on evolution of efforts to transform University research into profitable business ventures

Spotlight Innovation, Inc. (OTCQB:STLT) today published a white paper reporting the progress and growth of the transfer and commercialization of university-generated research and intellectual property (IP).
Read more…


August 5, 2014
Spotlight Innovation signs second Letter of Credit with Denver Savings Bank

Spotlight Innovation, Inc. (OTCQB:STLT) has entered into a second Letter of Credit with Denver Savings Bank, located in Denver, Iowa, in the amount of $250,000.00, effective July 29, 2014.
Read more…


July 02, 2014
Spotlight Innovation, Inc., announces closing of financing

Spotlight Innovation, Inc., (OTCQB:STLT) is pleased to announce that it has closed an equity placement of more than $41,418,000 with nine accredited investors, through its equity advisor Catwalk Capital, LLC.
Read more…


June 26, 2014
Spotlight Innovation names Dr. David Hostelley Chief Financial Officer

Spotlight Innovation, Inc. (OTCQB:STLT) today announced that effective June 20, 2014, Dr. David Hostelley has been named Chief Financial Officer of the Company.
Read more…


June 17, 2014
Spotlight Innovation building relationships with Midwest businesses and people

Cristopher Grunewald, President and CEO of Spotlight Innovation said, “The Midwest is a hotbed of talent and innovation, and it has always been a pillar of our business plan to build relationships with people and institutions in the Midwest. We are pleased that we are making good on this commitment.”
Read more…


June 10, 2014
Spotlight Innovation subsidiary Celtic Biotech Iowa, Inc., completes merger with Celtic Biotech Ltd.

Spotlight Innovation, Inc. (OTCQB:STLT) today announced that effective June 4, 2014, Celtic Biotech Iowa, Inc. (a subsidiary of Spotlight Innovation, Inc.) has completed a share exchange agreement with biopharmaceutical company Celtic Biotech Ltd.
Read more…


December, 16, 2013
Spotlight Innovation’s name change, symbol change and reverse split approved by FINRA

Spotlight Innovation, Inc. (“the Company”) (OTCQB:STLT) is pleased to announce that effective December 17, 2013 the Financial Industry Regulatory Authority (“FINRA”) has approved the name change of the company from American Exploration Corp. to Spotlight Innovation, Inc., change of stock symbol to “STLT”, and a 1-500 reverse split of our common stock.
Read more…


December 12, 2013
Spotlight Innovation, Inc. Announces Name Change and Closing of Merger

Spotlight Innovation, Inc. (formerly American Exploration Corporation, AEXP:OTCQB), announced today the completion of a merger with Spotlight Innovation, LLC.
Read more…


Spotlight Innovation is committed to developing quality-of-life-enhancing biotechnologies that have the potential to positively impact the health, well-being and longevity of an enormous number of lives. We are building a portfolio of healthcare/life sciences subsidiary companies, each having the potential to further our commitment.

Celtic Biotech Iowa Inc.

Celtic Biotech, Inc.

Celtic Biotech Iowa Inc., is developing novel therapeutic products for the treatment of cancers and pain in humans. Derived from naturally specialized receptor-binding proteins, these products have the potential to reduce treatment costs, increase survivability, and improve the quality of life for cancer patients.

Celtic Biotech Iowa Inc. is a subsidiary of Spotlight Innovation Inc.

Read the press release here.

Additional information about Celtic Biotech here.

Celtic Biotech Iowa Inc.

  

Management

Cristopher Grunewald, CEO

Mr. Grunewald is a financial executive and entrepreneur with background in the healthcare and biotechnology sectors, private equity and investment banking. He has been involved in all stages of the commercialization of healthcare IP developed by premiere research and development institutions.

Dr. David Hostelley, CFO

Dr. Hostelley has twenty years as a consultant in the health field, and has served as CEO, CFO and board member of several publicly traded companies. Dr. Hostelley is a CPA (inactive) licensed by the state of Ohio. He earned his Ph.D. in management while a lecturer in the MBA Program of Baldwin-Wallace College, and has lectured in Accounting and Management for Walsh University, North Canton, Ohio.

Jeffrey Stein, Esq., Securities Counsel

Mr. Stein serves as securities counsel for Spotlight Innovation. He has over fifteen years of experience providing high quality, personalized attention to public companies, including more than thirty reverse mergers, IPOs and APOs.

Rene Erickson, Corporate Communications

Mr. Erickson has three decades of corporate communications experience across diverse industries including healthcare, information technology, aviation and academia.

Mike Reysack, Investor Relations

Mr. Reysack leads Investor Relations for Spotlight Innovation. He has extensive experience cultivating and managing relationships with financial stakeholders, including fifteen years as an Investor Relations consultant and business strategist for venture and early stage companies, providing effective communications between companies and the financial community.

Special Advisor

Jerry Cirino

Mr. Cirino is a healthcare technology executive with extensive background in medical devices, distribution and healthcare information in private equity and public environments. His experience includes management of complex growth and transition environments including M&A, integrations and global operations, and he is a proven consultant in transaction evaluation, due diligence and strategic planning.

Partner Firms

Auditor

GBH CPAs, PC, Houston, TX

Transfer Agent

VStock Transfer, LLC, Woodmere, NY

Law Firms

Davis Brown Law Firm, Des Moines, IA
JMS Law Group, New York, NY
Eilers Law Group, Miami, FL
Whitfield & Eddy, P.L.C., Des Moines, IA




 

SureTrader
Interactive Brokers Advertisement
STLT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#1448  Sticky Note The 8-K filled today by STLT explains this Ecomike 08/30/16 02:59:59 PM
#1588   Solid increase in buying volume here today. Breakout Ecomike 10/24/17 11:19:21 AM
#1587   I agree, I have seen no signs of Ecomike 10/21/17 07:39:46 PM
#1585   https://www.stockscores.com/charts/charts/?ticker=STLT mick 10/08/17 02:52:46 PM
#1584   the next few weeks will be critical here Ecomike 09/23/17 07:53:26 PM
#1583   Well it had a nice drop, I picked PennyStockTrader2 09/14/17 08:22:52 PM
#1582   Spotlight Innovation (STLT) mick 08/25/17 11:09:54 AM
#1581   10-Q was filed today. They hired a new Ecomike 08/17/17 09:54:37 PM
#1580   Notice of late filling Monday :( Ecomike 08/15/17 01:43:00 PM
#1579   Well, it has remained quiet here, certainly there PennyStockTrader2 08/15/17 12:15:37 PM
#1578   Convertible debt death-shark-banksters are known for shorting a Ecomike 08/09/17 02:49:43 PM
#1577   Based on the stock price history, I cannot PennyStockTrader2 08/08/17 12:45:58 PM
#1576   I'm ready to buy a lot, but not Ecomike 08/08/17 12:32:24 PM
#1575   Well I am on the bid at a PennyStockTrader2 08/08/17 11:36:30 AM
#1574   Thanks for the heads up, didnt see the PennyStockTrader2 08/07/17 04:46:51 PM
#1573   This is one sick puppy today, major news Ecomike 08/07/17 03:28:48 PM
#1572   If you have the time and interest, maybe PennyStockTrader2 08/04/17 09:08:28 PM
#1571   The diluters may be collected weekly lots of Ecomike 08/04/17 01:14:03 PM
#1570   Thanks for your insight, I appreciate it. PennyStockTrader2 08/02/17 06:56:51 PM
#1569   It was not hard to see this coming Ecomike 08/02/17 05:48:46 PM
#1568   74,500 dumped in one order at .101 today, Ecomike 08/02/17 05:47:46 PM
#1567   Yes indeed, came as a surprise, but I PennyStockTrader2 08/02/17 05:33:36 PM
#1566   A new 52 week low. junkHustler 08/02/17 03:54:57 PM
#1565   Somehow this dropped into the mid-teens today and PennyStockTrader2 07/24/17 09:35:33 PM
#1564   Spotlight Innovation (STLT) mick 07/12/17 08:26:45 AM
#1563   This continues to be a buy under 25, PennyStockTrader2 07/08/17 04:30:52 PM
#1562   Spotlight Innovation to Present Poster at the Cure subslover 06/22/17 12:45:10 PM
#1561   Surprise surprise. junkHustler 06/22/17 12:40:24 PM
#1560   They must know its was orchestrated by their subslover 06/21/17 11:46:57 PM
#1559   Come to Papa!!!!! Let's test that bottom, LOL, Ecomike 06/20/17 10:46:41 AM
#1558   Why people not posting here any more? I marina22 06/18/17 11:05:48 AM
#1557   Nice call dude!!!! subslover 06/15/17 08:45:26 PM
#1556   Expect a quick spike in the morning $$$$$$ Tha Part Time Er 06/14/17 10:22:57 PM
#1555   Hope your correct. The stock has no bid subslover 06/14/17 08:47:31 PM
#1554   Tomorrow should be epic IMO chasem 06/14/17 08:43:32 PM
#1553   Promo tomorrow Triple nickle 06/14/17 07:57:58 PM
#1552   Nice News out subslover 06/14/17 10:05:06 AM
#1551   Is everyone ready!! chasem 06/14/17 08:43:27 AM
#1550   Wow, that is a great gesture, I would PennyStockTrader2 06/12/17 03:12:43 PM
#1549   $STLT NEWS IS OUT http://ir.spotlightinnovation.com/press-releases/detail/75 subslover 06/08/17 09:26:27 AM
#1548   Lackluster Morning. Hope buying picks up this afternoon. subslover 06/02/17 12:01:40 PM
#1547   Pre-market trades:-) WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE midtownmurphy 06/02/17 09:29:49 AM
#1546   Can't wait for the open!! Hoping for the trifecta!!! midtownmurphy 06/02/17 07:32:59 AM
#1545   Excellent close Murphy,keep the positive energy flowing! subslover 06/01/17 04:36:28 PM
#1544   Actually it makes a huge difference, I could Ecomike 06/01/17 03:44:15 PM
#1543   I totally appreciate this info Ecomike its very subslover 06/01/17 03:30:45 PM
#1542   We sure are Sub. Moving back to the midtownmurphy 06/01/17 02:36:34 PM
#1541   This thing could go back to multiple dollars fast!!! Ecomike 06/01/17 01:43:22 PM
#1540   giddy up!!! midtownmurphy 06/01/17 01:34:11 PM
#1539   That is an absolute HUGE HUGE find! I subslover 06/01/17 12:57:44 PM
#1538   Spotlight Innovation (STLT) mick 06/01/17 12:41:55 PM
PostSubject